The US Department of Justice has launched an investigation into alleged price manipulation and coordination of music licensing agreements, according to anonymous sources.
Reports say the music publishing units of Sony, Universal Music, and the American Society of Composers, Authors & Publishers are all part of the DOJ’s investigation. The ASCAP collects licensing fees on behalf of music publishers and songwriters.
The DOJ was reported to have launched a market inquiry earlier this year into music licensing practices as the industry shifts towards Internet music streaming services like Pandora and Spotify. Music streaming rights have been the subject of regulatory scrutiny as rights owners fight Pandora Media over licensing fees; similarly, YouTube has been involved in conflict with independent music labels over licensing agreements. YouTube has threatened to remove music from indie labels from its video streaming site unless the parties can agree on licensing terms.
The DOJ announced last June that it was looking into highly outdated music licensing agreements with the ASCAP and Broadcast Music that regulate songwriter royalties, according to reports.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas